Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|August 8, 2019
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathyRicha Manwani, Shameem Mahmood, Sajitha Sachchithanantham, et al.
Frontiers in Oncology|August 9, 2021
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple MyelomaCatherine S Y Lecat, Jessica B Taube, William Wilson, et al.
The Lancet. Haematology|December 22, 2015
Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational studyShameem Mahmood, Frank Bridoux, Christopher P Venner, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 8, 2017
Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centreThirusha Lane, Jennifer H Pinney, Janet A Gilbertson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 6, 2018
Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosisTamer Rezk, Janet A Gilbertson, Dorota Rowczenio, et al.
British Journal of Haematology|May 25, 2019
Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkersTamer Rezk, Helen J Lachmann, Marianna Fontana, et al.
Heart (British Cardiac Society)|June 28, 2022
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosisOliver C Cohen, Ananth Sathyanath, Aviva Petrie, et al.
Transplantation|February 1, 2020
Amyloidosis Diagnosed in Solid Organ Transplant RecipientsFaye A Sharpley, Marianna Fontana, Janet A Gilbertson, et al.
British Journal of Haematology|January 3, 2024
Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosisJahanzaib Khwaja, Joshua Bomsztyk, Maria Atta, et al.
British Journal of Haematology|January 28, 2020
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light-chain amyloidosisOliver C Cohen, Faye Sharpley, Julian D Gillmore, et al.
Pageof 6